XML 367 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustments
Paid-in Capital
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustments
Retained Earnings
Treasury Stock, at cost
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjustments
Total
Beginning Balance at Dec. 31, 2020 $ 253   $ 767,484   $ 378,906 $ (827,381) $ (35,701)   $ 283,561
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Total comprehensive income (loss)         (6,042)   1,337   (4,705)
Employee stock-based compensation     3,885   18       3,903
Issuance of shares of common stock under long-term incentive plan 1               1
Common stock withheld related to net share settlement of equity awards     (1,317)           (1,317)
Ending Balance at Mar. 31, 2021 254   770,052   372,882 (827,381) (34,364)   281,443
Beginning Balance at Dec. 31, 2020 253   767,484   378,906 (827,381) (35,701)   283,561
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Total comprehensive income (loss)                 119,511
Ending Balance at Sep. 30, 2021 254   779,013   489,914 (827,381) (27,157)   414,643
Beginning Balance at Mar. 31, 2021 254   770,052   372,882 (827,381) (34,364)   281,443
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Total comprehensive income (loss)         27,866   4,584   32,450
Employee stock-based compensation     4,613   23       4,636
Ending Balance at Jun. 30, 2021 254   774,665   400,771 (827,381) (29,780)   318,529
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Total comprehensive income (loss)         89,143   2,623   91,766
Employee stock-based compensation     4,343           4,343
Issuance of shares of common stock for warrants exercised     5           5
Ending Balance at Sep. 30, 2021 254   779,013   489,914 (827,381) (27,157)   414,643
Beginning Balance at Dec. 31, 2021 255   784,356   712,478 (827,381) 14,158   683,866
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Dividends on common shares         (3,851)       (3,851)
Dividend Equivalents earned on RSU grants         (420)       (420)
Total comprehensive income (loss)         271,872   1,423   273,295
Employee stock-based compensation     8,203           8,203
Issuance of shares of common stock under long-term incentive plan 1               1
Common stock withheld related to net share settlement of equity awards     (4,827)           (4,827)
Issuance of shares of common stock for warrants exercised     506           506
Ending Balance (ASU 2020-06) at Mar. 31, 2022   $ (39,239)   $ 6,718       $ (32,521)  
Ending Balance at Mar. 31, 2022 256   748,999   986,797 (827,381) 15,581   924,252
Beginning Balance at Dec. 31, 2021 255   784,356   712,478 (827,381) 14,158   683,866
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Total comprehensive income (loss)                 851,488
Ending Balance at Sep. 30, 2022 286   766,427   1,299,024 (884,879) 5,203   1,186,061
Beginning Balance at Mar. 31, 2022 256   748,999   986,797 (827,381) 15,581   924,252
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Dividends on common shares         (150,716)       (150,716)
Dividend Equivalents earned on RSU grants         (8,665)       (8,665)
Total comprehensive income (loss)         407,563   (8,901)   398,662
Employee stock-based compensation     6,349           6,349
Common stock withheld related to net share settlement of equity awards     (81)           (81)
Issuance of shares of common stock for convertible debt exchanged 26   (29)           (3)
Issuance of shares of common stock for warrants exercised 4   18,906           18,910
Ending Balance at Jun. 30, 2022 286   774,144   1,234,979 (827,381) 6,680   1,188,708
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Dividends on common shares         (110,071)       (110,071)
Dividend Equivalents earned on RSU grants     464   (6,891)       (6,427)
Total comprehensive income (loss)         181,007   (1,477)   179,530
Employee stock-based compensation     6,285           6,285
Cash paid for convertible debt repurchased     (14,466)           (14,466)
Purchase of common stock under share repurchase program           (57,498)     (57,498)
Ending Balance at Sep. 30, 2022 $ 286   $ 766,427   $ 1,299,024 $ (884,879) $ 5,203   $ 1,186,061